Ubc13 antibody | knockout validation | Invitrogen/Zymed 37-1100
DOI
//dx.doi.org/10.13070/ko.en.6.1787
Date
2016-11-08

This is a knockout-validated antibody summary, based on the publication " The human T-cell leukemia virus type 1 Tax oncoprotein requires the ubiquitin-conjugating enzyme Ubc13 for NF-kappaB activation", as cited below [1]. Labome curates formal publications to compile a list of antibodies with unambiguous specificity within Validated Antibody Database (VAD).

Ubc13 antibody | knockout validation | Invitrogen/Zymed 37-1100 figure 1
Figure 1. Western blot of wild-type and Ubc13 -/- murine embryonic fibroblasts probed with anti-Ubc13 antibody (Invitrogen, Cat No. 37-1100). Actin serves as a loading control. From [1].
Antibody information

Mouse monoclonal

Company: Invitrogen

Antibody: Ubc13

Catalog number: 37-1100 Clone 4E11

Summary: Mouse monoclonal antibody raised against recombinant human Ubc1.

Supplier recommended for elisa, IF and WB.

Reacts with human, mouse and rat Ubc13.

Validation Method

Western blot

Sample

Lysates of wild-type and UBC13 -/- murine embryonic fibroblasts.

Blocking agent

5% dried milk powder.

Detection

Western Lightning ECL Reagent (Perkin Elmer).

References
  1. Shembade N, Harhaj N, Yamamoto M, Akira S, Harhaj E. The human T-cell leukemia virus type 1 Tax oncoprotein requires the ubiquitin-conjugating enzyme Ubc13 for NF-kappaB activation. J Virol. 2007;81:13735-42 pubmed